April 4, 2013
/PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Heidelberg University Hospital,
, has treated the world's first patients with the new TomoEDGE™ Dynamic Jaws technology combined with
as part of its
. The new TomoEDGE Dynamic jaws technology was introduced at ASTRO 2012 as the newest evolution to the TomoTherapy System. The managing director of the department of radiotherapy,
, M.D., and
, M.D., radiation oncologist, both with Heidelberg University Hospital, were in charge of these first treatments at Heidelberg University Hospital.
"We treated our first patients on
March 25, 2013
using the TomoEDGE technology, and we have successfully treated both prostate and breast patients," said
, M.D., radiation oncologist with Heidelberg University Hospital. "With TomoEDGE we are now able to treat, faster, the entire spectrum of the radiation oncology patients."
"With the new TomoEDGE technology, we can provide the most precise and personalized treatment plans while also achieving significantly better dose distributions and at the same time reduce overall treatment time," added
, medical director of the department of radiation oncology and radiotherapy with Heidelberg University Hospital.
The new TomoEDGE technology allows for sharper dose sculpting and reduces treatment time for many patients by approximately half, which will enable clinics to treat more patients per day. TomoEDGE Dynamic Jaws are optimized to open dynamically as they sweep across the target. This combines the benefits of narrow jaw widths to better sculpt dose at the edges of the treatment volume with larger jaw widths to complete treatment in a shorter time. The result is a precise, yet faster and more customized treatment delivery that is as unique as each patient.